The global hydrate inhibitors market was valued at US$ 170.0 million in 2017, according to Hydrate Inhibitor Market Report, by Inhibitor Type (Thermodynamic Inhibitors, Low Dosage Hydrate Inhibitors (LDHI's), and Hybrid), published by Coherent Market Insights. The global hydrate inhibitors market is projected to reach US$ 290.3 million by 2025, exhibiting a CAGR of 6.9% during the forecast period.

Increasing shale gas production globally, is expected to boost demand for hydrate inhibitors. This is owing to that fact that hydrate inhibitors reduces formation of hydrates in gas production systems such as line blockages and plugs.

According to the U.S. Energy Information Administration, total shale production in the U.S. in 2014 was 13.4 trillion cubic feet, which increased to 15.2 trillion cubic feet in 2015, owing to advancement in horizontal drilling and hydraulic fracturing techniques and focus on newly discovered technically recoverable reserves.

However, technical and economic advantages over other inhibition methods have resulted in a booming hydrate inhibitor market. Remediation measures such as pigging, depressurization of pipelines, jetting, solvent addition, heating are expensive and leads to increase in non-productive time.

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/hydrate-inhibitors-market-555

Key Trends and Analysis of the Hydrate Inhibitors Market:

Low Dosage Hydrate Inhibitor (LDHI) segment held a significant market share in 2017 in the global hydrate inhibitors market, due to key players focusing on new product launches and development of novel technology in this segment. For instance, in September 2016, Nalco, a subsidiary of the Ecolab Inc., expanded its portfolio of low-dosage hydrate inhibitors for use in the Gulf of Mexico. The new line of products with anti-agglomerant technology allows to simplify logistics, reduce safety risk, and increase production while sustaining assets and lowering the total cost of operation.
Key Takeaways of the Market:

Europe is a lucrative market for hydrate inhibitors with significant demand due to high offshore oil production from the region in 2017. Germany, France, and the U.K. were the major contributors to growth of this market. For instance, according to the EU, 567 million barrels of offshore oil had been produced in the U.K. in 2012. Furthermore, 95 million barrels of offshore oil and 105 million barrels of offshore gas production was recorded in Norway in 2012, according to the EU.
In addition to this, according to the data provided by the UK Parliament, U.K. actively focuses on exploration and production of oil and gas (mostly offshore) and in 2016, around 80% of the U.K.'s primary energy needs were met by fossil fuels. Thus, growing oil and gas sector in the region is anticipated to support the market growth as well.
Middle East region held significant market share in global hydrate inhibitors market in 2017. This is due to key players in the region investing in new projects. The Oman Oil Company invested over US$1 billion in oil and gas projects in 2017 in the region. This accompanied by the development of the Khazzan tight gas field in partnership with BP Plc. is also expected to aid in growth of the market.
Key players are strategically investing in mergers and acquisitions to enhance their market share and remain competitive in the market. For instance, in 2017, Schlumberger acquired all outstanding shares of Cameron International Corporation, a leading provider of flow equipment products, services, and systems to the oil and gas industry in Africa.
Major players operating in the global hydrate inhibitors market includes Halliburton, Ashland Global Specialty Chemicals Inc., Ecolab Inc., Baker Hughes Inc., Innospec Inc., JSC Gazprom Neftekhim Salavat, BASF SE, Evonik Industries Ag, Clariant AG, GasHydrate LLC, and Schlumberger Limited.

Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness substantial growth from 2024 to 2034, driven by the rising prevalence of IPF, advancements in drug development, and an increasing focus on early diagnosis and treatment. The market is proj...

Europe Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness significant growth between 2024 and 2034, driven by the increasing prevalence of IPF, advancements in drug development, and improved diagnostic methods. The market is projected to reach USD XX.X...

North America Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Idiopathic Pulmonary Fibrosis (IPF) Market is projected to experience robust growth from 2024 to 2034, driven by advancements in therapeutic options, increasing prevalence of IPF, and a growing emphasis on early diagnosis and treatment. The market size ...

Global Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Idiopathic Pulmonary Fibrosis (IPF) Market is poised to experience significant growth between 2024 and 2034, driven by advancements in drug development, increasing prevalence of IPF, and heightened awareness about the disease. Valued at USD XX.XX billion in 20...

Platelet-Derived Growth Factor Receptor Inhibitors Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Platelet-Derived Growth Factor Receptor Inhibitors Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competi...

Global Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes), By Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...

Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) ...

Executive Summary Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...

2023-2028 Global and Regional Oilfield Shale Inhibitors Industry Status and Prospects Professional Market Research Report Standard Version...

The global Oilfield Shale Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in...

2023-2028 Global and Regional Shale Inhibitors Industry Status and Prospects Professional Market Research Report Standard Version...

The global Shale Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fie...

2023-2028 Global and Regional Cadmium Chloride Hydrate Industry Status and Prospects Professional Market Research Report Standard Version...

The global Cadmium Chloride Hydrate market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...